Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Acetazolamide 40mg/5ml oral liquid
1106000B0AAAWAW
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 425mg/5ml oral liquid
1106000B0AAA4A4
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 500mg/5ml oral liquid
1106000B0AAAXAX
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 50mg/5ml oral liquid
1106000B0AAAVAV
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 5mg/5ml oral liquid
1106000B0AABHBH
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 62.5mg/5ml oral liquid
1106000B0AAAUAU
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 65mg/5ml oral suspension
1106000B0AABRBR
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 75mg/5ml oral liquid
1106000B0AABIBI
|
Acetazolamide | Acetazolamide | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.